Norbert Riedel

(Dr. Norbert Riedel Ph.D.)

Currently holds positions in Oscient Pharmaceuticals Corp, Jazz Pharmaceuticals PLC and Aptinyx Inc

Positions

Position Company Period
Director Oscient Pharmaceuticals Corp Jan. 1, 1999 -
Independent Director Jazz Pharmaceuticals PLC May 2, 2013 -
President, Chief Executive Officer, Director Aptinyx Inc June 1, 2015 -
Independent Director ARIAD Pharmaceuticals Inc April 28, 2011 - Feb. 16, 2017
Deputy Chairman of the Supervisory Board Medigene AG Oct. 27, 2003 - July 16, 2013
Corporate Vice President, Chief Scientific Officer Baxter International Inc May 1, 2001 - Jan. 1, 2012
Norbert Riedel's trades of Jazz Pharmaceuticals PLC's stock


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PS: Planned sale, O: Option / Other
Notification date Transaction date B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2023-08-15 2023-08-14
S Sale
1,241 -8.3%
138.16
USD 171,454 		1,241 -8.3% 138.16 USD 171,454
2022-08-09 2022-08-08
S Sale
1,089 -8.4%
152.32
USD 165,877 		1,089 -8.4% 152.32 USD 165,877
2022-08-09 2022-08-05
S Sale
8,000 -43.5%
155.87
USD 1,246,920 		8,000 -43.5% 155.87 USD 1,246,920
2021-12-08 2021-12-06
US Aptinyx Inc (APTX)
B Purchase
100,000 +inf%
2.23
USD 223,000 		100,000 +inf% 2.23 USD 223,000
2020-08-10 2020-08-07
S Sale
931 -9.0%
125.87
USD 117,186 		931 -9.0% 125.87 USD 117,186
2020-01-14 2020-01-10
US Aptinyx Inc (APTX)
B Purchase
35,000 +inf%
3.00
USD 105,000 		35,000 +inf% 3.00 USD 105,000
2018-08-13 2018-08-10
S Sale
660 -9.2%
176.61
USD 116,563 		660 -9.2% 176.61 USD 116,563
2016-08-17 2016-08-15
S Sale
633 -11.3%
136.45
USD 86,373 		633 -11.3% 136.45 USD 86,373
2016-05-17 2016-05-16
S Sale
644 -13.2%
145.20
USD 93,509 		644 -13.2% 145.20 USD 93,509
// ... existing code ... // ... rest of the file ...